Ryan Egeland

Dr Ryan Egeland leads Solventum’s Global Medical and Clinical Affairs team. Prior to joining Solventum, Dr Egeland served as chief executive officer of Crossfire Medical. He previously held senior leadership roles at Cardiovascular Systems, Inc. (CSI) as head of Strategic Ventures and chief medical officer, and he led teams across business development, medical and scientific affairs, and product marketing at Medtronic, Covidien, and ev3. 

Dr Egeland earned his MD from Harvard Medical School and was a Rhodes Scholar at the University of Oxford, where he completed his PhD in Biomolecular Engineering and MBA. He trained in plastic and reconstructive surgery at Northwestern Memorial Hospital and has worked in both academic and private clinical settings. He currently serves on the boards of Piraeus Medical and Vergent Bioscience.